Page 6 - Michael Matson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Markets Needham analyst Michael Matson maintained a Hold rating on LivaNova (LIVN – Research Report) today. The company’s shares closed last Wednesday at $87.05. According to TipRanks.com, Matson is a 5-star analyst with an average return of 17.3% and a 72.0% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings. LivaNova has an analyst consensus of Moderate Buy, with a price target consensus of $88.00. LivaNova’s market cap is currently $4.03B and has a P/E ratio of -11.60. The ...

Markets Needham analyst Michael Matson assigned a Hold rating to Steris (STE – Research Report) today. The company’s shares closed last Monday at $216.47, close to its 52-week high of $216.74. According to TipRanks.com, Matson is a 5-star analyst with an average return of 17.4% and a 71.8% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Steris with a $227.00 average price target. The comp...